Alerts will be sent to your verified email
Verify Email
AARTIPHARM
|
Aarti Pharmalabs
|
Acutaas Chemicals
|
Shilpa Medicare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.89 % | 18.21 % | 5.0 % |
|
5yr average Equity Multiplier
|
1.37 | 1.75 | 1.64 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.82 | 0.39 |
|
5yr Avg Net Profit Margin
|
7.96 % | 12.12 % | 7.72 % |
|
Price to Book
|
3.98 | 6.85 | 4.04 |
|
P/E
|
30.8 | 56.22 | 137.4 |
|
5yr Avg Cash Conversion Cycle
|
89.79 Days | 58.6 Days | 76.54 Days |
|
Inventory Days
|
92.09 Days | 65.78 Days | 105.79 Days |
|
Days Receivable
|
95.5 Days | 111.06 Days | 113.53 Days |
|
Days Payable
|
69.05 Days | 142.05 Days | 120.58 Days |
|
5yr Average Interest Coverage Ratio
|
11.46 | 19.71 | 11.52 |
|
5yr Avg ROCE
|
10.86 % | 22.58 % | 6.65 % |
|
5yr Avg Operating Profit Margin
|
13.88 % | 19.73 % | 17.76 % |
|
5 yr average Debt to Equity
|
0.15 | 0.34 | 0.44 |
|
5yr CAGR Net Profit
|
n/a | 9.26 % | -27.23 % |
|
5yr Average Return on Assets
|
5.29 % | 10.12 % | 3.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.29 % | 35.96 % | 44.23 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 7.92 % |
|
Change in Promoter Holding (3 Yrs)
|
-1.69 % | -5.09 % | -5.78 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-4.33 % | 10.94 % | 3.04 % |
|
Aarti Pharmalabs
|
Acutaas Chemicals
|
Shilpa Medicare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Customer Segment
|
Customer Segment
|
-
|
-
|